Photo of Miranda R. Miller

Miranda R. Miller

AA Contact Info

Jacqueline Williams
Phone: 919.838.2050


Miranda Miller practices corporate and securities law, with an emphasis on representing private equity and venture capital investors, mezzanine lenders, the formation, financing and general representation of early-stage start-ups, public and private growth and technology and life science companies and closely-held businesses, and the representation of investors, shareholders and institutions involved with such companies. She regularly represents both companies and investors in a variety of corporate activities, including venture capital and private equity transactions, mergers and acquisitions, commercial contracts, public and private offerings, joint venture transactions and strategic partnerships and collaborations. She also advises companies and their directors and officers on corporate governance matters and other general corporate and business matters. In addition, Miranda's merger and acquisition practice includes representation of business entities in connection with Hart-Scott-Rodina filings and anti-trust planning.

Miranda practiced corporate law in the Raleigh office of an international law firm headquartered in Atlanta, Georgia and at one of the 20 largest global law firms in New York before she joined Smith Anderson in 2001.

  • American Bar Association
  • New York Bar Association
  • North Carolina Bar Association
    • Volunteer, NC LEAP (North Carolina Lawyers for Entrepreneurs Assistance Program), a project of the North Carolina Bar Association and the NCBA Foundation that provides free legal services to low-wealth entrepreneurs starting or expanding their businesses
    • Volunteer, Legal Aid Lawyer on the Line, a pro bono partnership between N.C. Legal Aid and the N.C. Bar that provides legal assistance to indigent clients
  • Raleigh City Farm, Chairman, Board of Directors
  • Wake County Bar Association

The Best Lawyers in America©, Venture Capital Law (2019, 2020)



  • Represented a national venture capital firm in a $1.35 billion secondary sale of securities in 31 portfolio companies
  • Represented a global contract research organization (CRO) in restructuring, $12.7 million equity financing and acquisition
  • Advised a SaaS company in its sale to a data integration public company
  • Represented a global contract research organization (CRO) in acquisition of services company for up to $28 million and $6 million preferred equity financing
  • Represented a global contract research organization (CRO) in $60 million equity and secured debt financing
  • Represented the institutional shareholders in connection with the $143 million sale of a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries
  • Represented a global solid state LED lighting and semiconductor manufacturing company in connection with its announced agreement for its $850 million sale of assets to a publicly traded German semiconductor company. The transaction was terminated before completion due to regulatory considerations
  • Advised a semiconductor and LED company on the divestiture of its lighting products business unit for an initial cash payment of $225 million plus the potential to receive an earn-out payment based on the business’s post-closing performance
  • Represented a regional venture capital fund in formation of life science portfolio company and Series A equity financing
  • Represented a specialty pharmaceutical company in a $120 million merger with a subsidiary of a publicly-traded international pharmaceutical company
  • Advised a publicly traded health services company in the acquisition of a health services division of a privately held company for $105 million in cash
  • Represented a biopharmaceutical-focused private equity firm in formation of portfolio company and $25 million Series A equity financing
  • Represented various lenders in equity co-investments in portfolio companies
  • Represented a life science company in equity and debt financings, providing general corporate advice, including advice on equity compensation
  • Represented a company in $25 million in preferred stock financing by major financial investor
  • Represented a medical device maker in start-up matters and equity financing
  • Represented a national venture capital fund in multiple early stage investments in technology and life science portfolio companies
  • Represented a life science company in $50 million mezzanine financing
  • Represented a regional venture capital firm in Series B financing in specialty pharmaceutical company
  • Represented lender in wind-down of distressed portfolio company
  • Represented early stage health care information company in Series A financing
  • Represented major health insurance company's private investment arm in early stage investment in health care technology company
  • Represented agbio company in all stages of equity financing, beginning with Series A round and culminating in its acquisition by global ag bio entity  
  • Advised a private equity fund in its acquisition of a specialty pharmaceutical company

News & Publications

Speaking Engagements


  • CLE titled, Art of the Venture Deal: Debt Financing for Early-Stage Companies, series hosted at Smith Anderson’s office, Raleigh, N.C., November 2013
  • CLE titled, Art of the Venture Deal: Financing alternatives for start-up companies, series hosted at Smith Anderson's office, Raleigh, N.C., November 2012

Bar & Court Admissions

  • North Carolina
  • New York


Columbia University, J.D., 1994

University of California, Berkeley, B.S., 1986

Lawyer Directory
Back to Page